Press Release HOME > NEWS > Press Release PharmCADD is growing to be a global company. READ MORE PharmCADD participated in 2022 Global IR @JPM Virtual Demo Day. READ MORE “The first AI-based mRNA vaccine will be launched into the world in 2022.” said PharmCADD CEO. READ MORE AI-based drug development is becoming a game changer. READ MORE PharmCADD participated the special donation activity of Salvation Army READ MORE PharmCADD will open Pharmulator ver. 2.5 and PharmVAC, AI-based drug discovery platforms during CES 2022. READ MORE The love of neighbors from PharmCADD READ MORE “I am sure that our company can commercialize the mRNA vaccine which has less side effect than the vaccines of Moderna or Pfizer”, said Eyegene CTO. READ MORE PharmCADD won a Patent Management Award from Ministry of Science and ICT. READ MORE « Previous Page1 Page2 Page3 Page4 Page5 Page6 Page7 Page8 Page9 Next »
“The first AI-based mRNA vaccine will be launched into the world in 2022.” said PharmCADD CEO. READ MORE
PharmCADD will open Pharmulator ver. 2.5 and PharmVAC, AI-based drug discovery platforms during CES 2022. READ MORE
“I am sure that our company can commercialize the mRNA vaccine which has less side effect than the vaccines of Moderna or Pfizer”, said Eyegene CTO. READ MORE